Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers
Abstract In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic n...
Saved in:
Published in | Inhalation toxicology Vol. 26; no. 13; pp. 789 - 810 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa Healthcare USA, Inc
01.11.2014
Taylor & Francis |
Subjects | |
Online Access | Get full text |
ISSN | 0895-8378 1091-7691 1091-7691 |
DOI | 10.3109/08958378.2014.953276 |
Cover
Loading…
Abstract | Abstract
In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers. |
---|---|
AbstractList | Abstract
In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers. In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers.In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers. In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC ( ) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers. In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC ( 2002 ) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers. In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers. |
Author | Maxim, L. Daniel Utell, Mark J. Greim, Helmut Niebo, Ron |
Author_xml | – sequence: 1 givenname: Helmut surname: Greim fullname: Greim, Helmut email: postsf@aol.com, postsf@aol.com organization: Institute of Molecular Pharmacology and Toxicology, Technical University – sequence: 2 givenname: Mark J. surname: Utell fullname: Utell, Mark J. email: postsf@aol.com, postsf@aol.com organization: Department of Medicine and Environmental Medicine, University of Rochester School of Medicine and Dentistry – sequence: 3 givenname: L. Daniel surname: Maxim fullname: Maxim, L. Daniel email: postsf@aol.com, postsf@aol.com organization: Everest Consulting Associates – sequence: 4 givenname: Ron surname: Niebo fullname: Niebo, Ron email: postsf@aol.com, postsf@aol.com organization: Everest Consulting Associates |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25264933$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAURi1URKeFN0DIy7LI4N8k7qIVGlFAqgRCsESWx7lpXCX2YHtazdvjMG1FWZSVF_d837XuOUIHPnhA6DUlS06JekdaJVvetEtGqFgqyVlTP0OLMqJVUyt6gBYzUs3MITpK6ZoQUhPevECHTLJaKM4X6OdXiGkDNrsbSDh4HKGPxuYQd9hCNJOzuHdriPjk2-riLbYmWufDFXhnXd6dYhumjYkuBZ_wrcsDDnko9J9Meome92ZM8OruPUY_Lj58X32qLr98_Lx6f1lZSVWuDGOdVb3qWKdYrVSnRCsZM1RaYSQjhvC2axjnUK-bWnZgFSe0bXtDAdRa8mN0tu_dbNcTdBZ8jmbUm-gmE3c6GKcfT7wb9FW40YIJSRtRCk7uCmL4tYWU9eSShXE0HsI2aVozQhgXDSnom793PSy5v2kBxB6wMaRU7vmAUKJndfpenZ7V6b26Ejv9J1YObLIL84_d-L_w-T7sfB_iZG5DHDudzW4Msfj01qU5_WTD2aOGAcyYh6Ib9HXYRl_0Pf2F327Rxlc |
CitedBy_id | crossref_primary_10_1016_j_taap_2018_06_011 crossref_primary_10_1007_s00210_024_03315_0 crossref_primary_10_1016_j_yrtph_2015_07_029 crossref_primary_10_1080_10937404_2016_1193361 crossref_primary_10_1007_s10973_016_5367_0 crossref_primary_10_1039_D3EN00041A crossref_primary_10_3390_cancers12113384 crossref_primary_10_3109_08958378_2015_1051640 crossref_primary_10_1080_08958378_2017_1394931 crossref_primary_10_1080_08958378_2023_2167023 crossref_primary_10_1177_0748233719851699 crossref_primary_10_3390_ijerph15010042 crossref_primary_10_1080_08958378_2018_1448019 crossref_primary_10_1039_C6CS00895J crossref_primary_10_1007_s13530_015_0235_z crossref_primary_10_1134_S1087659619030039 crossref_primary_10_1080_10408444_2019_1568385 crossref_primary_10_1016_j_ceramint_2024_05_277 |
Cites_doi | 10.1136/oem.58.12.800 10.5271/sjweh.427 10.1136/oem.52.2.105 10.1080/08958370050198511 10.1002/ajim.4700220205 10.1093/jnci/58.3.587 10.2307/3428305 10.1186/1743-8977-2-8 10.1080/10408440802273156 10.2307/3432074 10.1289/ehp.94102s5133 10.1136/thx.52.6.507 10.1164/ajrccm-conference.2011.183.1_MeetingAbstracts.A4812 10.1006/rtph.1997.1153 10.1093/occmed/kqg051 10.1053/sonc.2002.30227 10.1164/ajrccm.157.4.9707131 10.1136/bmj.e8376 10.3109/08958379509015210 10.3109/08958379509015209 10.1016/j.rmr.2011.04.008 10.1136/thx.51.Suppl_2.S9 10.1006/rtph.2000.1409 10.3109/08958379409003042 10.1080/08958370701866040 10.1093/annhyg/26.5.569 10.1016/j.yrtph.2006.04.008 10.1016/0013-9351(82)90137-2 10.1002/ajim.20844 10.1002/ajim.20316 10.1378/chest.122.6.2224 10.1006/rtph.2001.1474 10.1080/08958370701821375 10.1093/toxsci/kfs171 10.1289/ehp.97105s51261 10.1080/08958370490505016 10.1378/chest.105.1.8 10.1023/A:1008239116237 10.1111/j.1349-7006.2011.02165.x 10.1016/S0940-2993(96)80084-4 10.1006/faat.1996.0017 10.1002/ajim.10263 10.1093/annhyg/27.2.157 10.1164/rccm.201210-1911OC 10.1289/ehp.9088311 10.1136/oem.52.2.97 10.1097/JOM.0b013e3181b68cef 10.1378/chest.121.6.2044 10.5271/sjweh.1957 10.1177/030089160709300104 10.1093/oxfordjournals.aje.a009717 10.1136/oem.2006.027748 10.1016/j.ajpath.2011.02.040 10.1097/00001648-199705000-00006 10.1056/NEJM196503182721104 10.1080/10408440701524592 10.1136/oem.2009.048033 10.5271/sjweh.49 10.1136/thorax.55.10.860 10.1007/BF00381385 10.1097/00001648-200207000-00013 10.1006/rtph.2000.1443 10.3892/mco.2013.197 10.5271/sjweh.2244 10.1080/089583700196103 10.1038/bjc.2013.514 10.2486/indhealth.MS1147 10.1006/taap.1998.8472 10.1177/1420326X9700600206 10.1111/j.1539-6924.1995.tb00312.x 10.1016/j.mrfmmm.2004.06.011 10.1097/01.jom.0000052968.43131.b5 10.3109/08958379609052913 10.2486/indhealth.39.161 10.1136/oem.2004.018531 10.1081/DCT-100100112 10.1080/089583799197203 10.1378/chest.105.1.144 10.1136/oem.57.7.488 10.1007/PL00014628 10.5694/mja11.10125 10.5271/sjweh.1145 10.1097/00043764-199107000-00008 10.5094/APR.2012.020 10.1023/A:1008871718323 10.1164/ajrccm.154.5.8912756 10.1165/rcmb.2009-0206TR 10.1183/09031936.96.09061206 10.1186/1746-1596-5-81 10.1016/j.yrtph.2011.02.009 10.1016/j.rmr.2012.02.012 10.1006/rtph.2001.1513 10.1002/ajim.20394 10.3109/10408444.2014.899558 10.1016/j.ejca.2007.09.018 10.5271/sjweh.1938 10.1093/annhyg/mef034 10.1016/S0003-4878(99)00018-6 10.2486/indhealth.39.65 10.4103/0019-5278.55124 10.2486/indhealth.39.183 10.1016/0013-9351(76)90009-8 10.1080/15298669391354612 10.4103/0019-5278.111753 10.1183/09031936.95.08122149 10.1097/JOM.0b013e31818345bb 10.1080/02786828608959100 10.1006/faat.1996.0031 10.5271/sjweh.2326 10.1016/S0003-4878(98)00026-X 10.1016/j.rmed.2005.04.017 10.3109/08958370903521224 10.1093/annhyg/41.inhaled_particles_VIII.224 10.1080/089583701752378142 10.1080/08958370390248888 10.1007/BF00385650 10.3109/08958379509015208 10.1080/089583701316941294 10.1136/oem.2007.035584 10.1164/rccm.201304-0655LE 10.1056/NEJMra050152 10.1007/s004200100240 10.1016/j.yrtph.2006.05.003 10.1136/oem.2003.010165 10.2486/indhealth.45.379 10.1002/1097-0142(19900315)65:6<1449::AID-CNCR2820650633>3.0.CO;2-0 10.1080/0002889758507347 10.1002/ijc.20820 10.1016/S0232-1513(87)80044-0 10.1080/104732299302189 10.1097/JOM.0b013e31825296fd 10.1183/09031936.93.05030281 10.1016/S0140-6736(79)92468-1 10.1080/15428119591016494 10.1007/s00204-010-0580-2 10.3109/08958378.2012.683892 10.1016/S0140-6736(05)73126-3 10.1080/089583701752378133 10.1097/00043764-199007000-00009 10.1093/annhyg/31.4B.731 10.1093/annhyg/28.3.333 |
ContentType | Journal Article |
Copyright | 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted 2014 2014 The Author(s). Published by Taylor & Francis. 2014 |
Copyright_xml | – notice: 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted 2014 – notice: 2014 The Author(s). Published by Taylor & Francis. 2014 |
DBID | 0YH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.3109/08958378.2014.953276 |
DatabaseName | Taylor & Francis Open Access Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1091-7691 |
EndPage | 810 |
ExternalDocumentID | PMC4245174 25264933 10_3109_08958378_2014_953276 953276 |
Genre | Review Article Comparative Study Review Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 00X 03L 08R 0BK 0R~ 0VX 29I 36B 4.4 53G 5GY 5VS AACCU AAJNR AALIY AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABCRQ ABDBF ABEIZ ABLKL ABPTK ABUPF ACENM ACFUF ACGEJ ACGFO ACGFS ACLSK ADCVX ADFCX ADRBQ ADXPE AECIN AEGXH AENEX AEOZL AEYQI AFAUU AFKVX AFQCT AFWLO AGAFX AGDLA AGFJD AGRBW AGYJP AIAGR AIJEM AIRBT AJEBJ AJWEG AJXHO AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AWYRJ BABNJ BLEHA BOHLJ BVLLS CAG CCCUG COF CS3 DEIEU DKSSO DLVIE DTRLO DU5 DZHFC EAP EAS EBC EBD EBS EBX EHN EJD EMB EMK EMOBN EPL EPT ESX F3I F5P H13 HZ~ J.N JFOCU KRBQP KWAYT KYCEM LJTGL M44 M4Z O9- P2P QRXOQ Q~Q RNANH RVRKI SV3 TFDNU TFL TFW TUS UHWXJ V1S ZE2 ~1N 0YH ABJNI ABLIJ ABXYU ACIEZ ACUHS ALYBC TBQAZ TERGH TUROJ AAGDL AAYXX ABWVI ADYSH AFRVT AMPGV CITATION ACKYO AOYHP CGR CUY CVF ECM EIF NPM NUSFT 7X8 5PM TASJS |
ID | FETCH-LOGICAL-c519t-a22dc9f9d2d92699d948522a15c4a520a038d7233e6b765dec930188fa1ee9b53 |
IEDL.DBID | 0YH |
ISSN | 0895-8378 1091-7691 |
IngestDate | Thu Aug 21 18:09:29 EDT 2025 Fri Jul 11 16:21:31 EDT 2025 Thu Apr 03 07:09:56 EDT 2025 Thu Apr 24 23:03:20 EDT 2025 Tue Jul 01 02:24:45 EDT 2025 Wed Dec 25 09:07:44 EST 2024 Tue Jul 04 19:22:13 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13 |
Keywords | epidemiology rock wool refractory ceramic fiber fiber dimensions pleural plaques mesothelioma Biopersistence |
Language | English |
License | open-access: http://creativecommons.org/licenses/by/3.0: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. This is an open-access article distributed under the terms of the CC-BY-NC-ND 3.0 License which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c519t-a22dc9f9d2d92699d948522a15c4a520a038d7233e6b765dec930188fa1ee9b53 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Review-3 content type line 23 Based in part on a talk presented at the International Conference “Advances and Controversies in Fibre Toxicology” at CMDC, Cranfield University, Cranfield, UK, 3–4 June 2014. |
OpenAccessLink | https://www.tandfonline.com/doi/abs/10.3109/08958378.2014.953276 |
PMID | 25264933 |
PQID | 1620023470 |
PQPubID | 23479 |
PageCount | 22 |
ParticipantIDs | pubmed_primary_25264933 proquest_miscellaneous_1620023470 informahealthcare_journals_10_3109_08958378_2014_953276 crossref_primary_10_3109_08958378_2014_953276 informaworld_taylorfrancis_310_3109_08958378_2014_953276 crossref_citationtrail_10_3109_08958378_2014_953276 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4245174 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-11-01 |
PublicationDateYYYYMMDD | 2014-11-01 |
PublicationDate_xml | – month: 11 year: 2014 text: 2014-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Inhalation toxicology |
PublicationTitleAlternate | Inhal Toxicol |
PublicationYear | 2014 |
Publisher | Informa Healthcare USA, Inc Taylor & Francis |
Publisher_xml | – name: Informa Healthcare USA, Inc – name: Taylor & Francis |
References | CIT0111 CIT0112 CIT0114 CIT0117 CIT0116 CIT0119 CIT0118 Letourneux M (CIT0113) 1999; 16 CIT0120 CIT0001 CIT0122 CIT0121 Davis JMG (CIT0055) 1986; 67 Warheit DB (CIT0191) 1994 Bolton RE (CIT0036) 1984; 2 Health Council of the Netherlands (DECOS) (CIT0083) 2010 CIT0124 CIT0005 CIT0126 CIT0004 CIT0125 CIT0007 CIT0128 CIT0127 CIT0009 Scientific Committee on Occupational Exposure Limits (SCOEL) (CIT0177) 2011 CIT0008 Desoubeaux N (CIT0058) 2001; 49 CIT0129 CIT0010 CIT0131 CIT0130 CIT0012 CIT0133 CIT0011 CIT0132 Thermal Insulation Manufacturers Association (TIMA) Nomenclature Committee (CIT0184) 1993 Environmental Resources Management (ERM) (CIT0066) 1995 Imperatori A (CIT0096) 2013; 5 International Agency for Research on Cancer (IARC) (CIT0098) 2002; 81 CIT0135 CIT0013 CIT0134 CIT0016 CIT0137 CIT0015 CIT0136 Agency for Toxic Substances and Disease Registry (ATSDR) (CIT0006) 2000 CIT0018 CIT0139 CIT0017 CIT0138 CIT0019 CIT0140 CIT0021 CIT0142 CIT0020 CIT0141 CIT0023 CIT0144 CIT0022 CIT0143 Rubin A-H (CIT0169) 1986; 10 Wong O (CIT0193) 1991; 48 Agence Française de Sécurité Sanitaire de l'Environment et du Travail (AFSSET) (CIT0003) 2007 Davis JM (CIT0054) 1988; 69 CIT0025 CIT0146 CIT0024 CIT0145 CIT0027 CIT0148 CIT0026 Gibbs GW (CIT0074) 1980; 30 CIT0147 CIT0029 CIT0028 Davis JMG (CIT0056) 1984; 2 Sandén Å (CIT0171) 1992; 5 Dement JM (CIT0057) 1990; 88 Browne K (CIT0041) 1983; 40 Robinson CF (CIT0165) 1982; 39 National Toxicology Program (NTP) (CIT0150) 2010 Federal Register (CIT0069) 2005; 70 Kauffer E (CIT0104) 2003; 47 Hwang C (CIT0093) 1983; 40 CIT0100 Eastes W (CIT0063) 1994; 20 Banks DE (CIT0014) 2011 CIT0109 CIT0102 CIT0101 CIT0103 CIT0106 CIT0105 CIT0108 CIT0107 Marsh G (CIT0123) 1996; 12 CIT0072 CIT0071 CIT0192 CIT0195 CIT0194 CIT0076 CIT0075 CIT0196 CIT0078 CIT0077 Cherrie J (CIT0048) 1986; 12 CIT0190 Hillerdal G (CIT0088) 2001 CIT0085 CIT0084 CIT0087 CIT0086 CIT0089 CIT0081 CIT0080 Walker AM (CIT0189) 2012; 24 CIT0094 Esman N (CIT0067) 1979; 40 CIT0097 CIT0099 Brown RC (CIT0040) 2005; 49 CIT0090 CIT0092 CIT0091 Lipworth L (CIT0115) 2009; 51 National Research Council (NRC) (CIT0149) 2000 Harber P (CIT0079) 1987; 29 CIT0030 CIT0151 CIT0032 CIT0153 CIT0031 CIT0034 CIT0155 CIT0033 CIT0154 CIT0157 CIT0035 CIT0156 CIT0038 Health Council of the Netherlands (DECOS) (CIT0082) 2011 CIT0159 CIT0037 CIT0158 CIT0160 CIT0162 CIT0161 CIT0043 CIT0164 CIT0042 CIT0045 CIT0166 CIT0044 Filiberti R (CIT0070) 2014; 86 CIT0047 CIT0168 CIT0046 CIT0167 CIT0049 Eastes W (CIT0064) 1996; 12 Newman LS (CIT0152) 1989 CIT0050 CIT0170 CIT0052 CIT0173 CIT0051 CIT0172 CIT0175 CIT0174 CIT0176 CIT0179 ACC (CIT0002) 2004 CIT0178 CIT0059 ILSI Working Group (CIT0095) 2005; 17 CIT0061 CIT0182 CIT0060 CIT0181 Reinhartz A (CIT0163) 2004 CIT0062 CIT0183 CIT0065 CIT0186 CIT0185 CIT0188 CIT0187 Lanphear BP (CIT0110) 1992; 7 Gevenois PA (CIT0073) 2006 CIT0180 CIT0068 18027165 - Crit Rev Toxicol. 2007;37(10):839-86 12708148 - J Occup Environ Med. 2003 Apr;45(4):440-50 16169910 - Occup Environ Med. 2005 Oct;62(10):665-9 8919265 - Exp Toxicol Pathol. 1996 Jan;48(1):3-12 11029264 - Regul Toxicol Pharmacol. 2000 Aug;32(1):14-21 8869346 - Thorax. 1996 Aug;51 Suppl 2:S9-15 9553658 - Ann Oncol. 1998 Feb;9(2):139-49 22584686 - Toxicol Sci. 2012 Aug;128(2):461-70 9794173 - Cancer Causes Control. 1998 Aug;9(4):411-6 2835925 - Ann Occup Hyg. 1987;31(4B):731-54 24401539 - Oncology. 2014;86(1):33-43 7882918 - Environ Health Perspect. 1994 Oct;102 Suppl 5:139-43 3045007 - Int Arch Occup Environ Health. 1988;60(6):389-93 10854503 - Occup Environ Med. 2000 Jul;57(7):488-94 2272328 - Environ Health Perspect. 1990 Aug;88:311-7 6614727 - Ann Occup Hyg. 1983;27(2):157-71 495442 - Am Ind Hyg Assoc J. 1979 Feb;40(2):108-17 10992539 - Thorax. 2000 Oct;55(10):860-3 15288528 - Mutat Res. 2004 Sep 3;553(1-2):5-9 954709 - Environ Res. 1976 Aug;12(1):59-74 9707503 - Toxicol Appl Pharmacol. 1998 Aug;151(2):262-75 22642290 - Inhal Toxicol. 2012 Jun;24(7):416-24 8804939 - Eur Respir J. 1996 Jun;9(6):1206-10 23776320 - Indian J Occup Environ Med. 2012 Sep;16(3):119-23 21742228 - Rev Mal Respir. 2011 Jun;28(6):e11-7 10590549 - Appl Occup Environ Hyg. 1999 Nov;14(11):759-67 10897848 - Rev Mal Respir. 1999 Dec;16(6 Pt 2):1270-7 3393849 - Scand J Work Environ Health. 1988 Jun;14(3):145-52 6295247 - Ann Occup Hyg. 1982;26(1-4):569-82 3812494 - Am J Ind Med. 1986;10(5-6):555-62 12074022 - Ann Occup Hyg. 2002 Mar;46(2):135-42 11846639 - Regul Toxicol Pharmacol. 2002 Feb;35(1):95-104 11570360 - Inhal Toxicol. 2001 Sep;13(9):755-72 23989951 - Br J Cancer. 2013 Oct 1;109(7):1965-73 21641383 - Am J Pathol. 2011 Jun;178(6):2587-600 14648356 - Inhal Toxicol. 2003 Dec;15(14):1387-419 20068227 - Am J Respir Cell Mol Biol. 2010 Feb;42(2):133-9 21539475 - Inhal Toxicol. 1995;7(4):469-502 11836664 - Semin Oncol. 2002 Feb;29(1):2-17 3026035 - Scand J Work Environ Health. 1986;12 Suppl 1:18-25 11563601 - Int Arch Occup Environ Health. 2001 Aug;74(6):383-95 23825744 - J Thorac Dis. 2013 Jun;5(3):205-6 9563743 - Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1226-33 21345360 - Regul Toxicol Pharmacol. 2011 Jun;60(1):84-92 16036750 - Inhal Toxicol. 2004 Oct-Nov;16(11-12):801-7 9115020 - Epidemiology. 1997 May;8(3):259-68 11341549 - Ind Health. 2001 Apr;39(2):183-5 6523093 - Scand J Work Environ Health. 1984 Oct;10(5):293-8 8742325 - Fundam Appl Toxicol. 1996 Feb;29(2):269-79 17634686 - Ind Health. 2007 Jun;45(3):379-87 21895596 - Med J Aust. 2011 Sep 5;195(5):271-4 11114786 - Inhal Toxicol. 2000 Dec;12(12):1141-72 21162719 - Diagn Pathol. 2010;5:81 20957726 - Am J Ind Med. 2010 Nov;53(11):1070-80 6307339 - Br J Ind Med. 1983 Aug;40(3):273-9 8666112 - Eur Respir J. 1995 Dec;8(12):2149-73 7757174 - Occup Environ Med. 1995 Feb;52(2):97-104 15090665 - Occup Environ Med. 2004 May;61(5):438-41 21173534 - Ind Health. 2011;49(2):166-72 1108627 - Am Ind Hyg Assoc J. 1975 Nov;36(11):811-9 10711399 - Drug Chem Toxicol. 2000 Feb;23(1):223-42 19730396 - J Occup Environ Med. 2009 Sep;51(9):1075-87 10380162 - Inhal Toxicol. 1999 Feb;11(2):111-30 7597255 - Risk Anal. 1995 Apr;15(2):181-95 15941656 - Respir Med. 2006 Jan;100(1):75-82 1772796 - Br J Ind Med. 1991 Dec;48(12):818-24 11341560 - Ind Health. 2001 Apr;39(2):65-74 11706147 - Occup Environ Med. 2001 Dec;58(12):800-10 91808 - Lancet. 1979 Nov 17;2(8151):1074 8912756 - Am J Respir Crit Care Med. 1996 Nov;154(5):1405-10 7239672 - IARC Sci Publ. 1980;(30):69-78 18686078 - Crit Rev Toxicol. 2008;38 Suppl 1:49-73 23101644 - Rev Mal Respir. 2012 Oct;29(8):1035-46 16586409 - Am J Ind Med. 2006 Jun;49(6):460-7 2848570 - Br J Exp Pathol. 1988 Oct;69(5):717-37 11407937 - Regul Toxicol Pharmacol. 2001 Jun;33(3):350-5 2839895 - Scand J Work Environ Health. 1988;14 Suppl 1:49-51 11350196 - Regul Toxicol Pharmacol. 2001 Apr;33(2):138-46 6299326 - Br J Ind Med. 1983 May;40(2):145-52 10905265 - Lancet. 2000 May 13;355(9216):1723-4 17099906 - Am J Ind Med. 2006 Dec;49(12):1066-9 7724842 - Regul Toxicol Pharmacol. 1994 Dec;20(3 Pt 2):S104-12 2872911 - Br J Exp Pathol. 1986 Jun;67(3):415-30 12724555 - Occup Med (Lond). 2003 May;53(3):209-12 4001900 - Scand J Work Environ Health. 1985 Apr;11(2):117-22 19749604 - J Occup Environ Med. 2009 Oct;51(10):1177-84 2167956 - J Occup Med. 1990 Jul;32(7):594-604 9400735 - Environ Health Perspect. 1997 Sep;105 Suppl 5:1261-3 7117223 - Environ Res. 1982 Aug;28(2):386-98 20737138 - Arch Toxicol. 2011 Mar;85(3):185-92 22796921 - J Occup Environ Med. 2012 Jul;54(7):781-8 18300048 - Inhal Toxicol. 2008 Feb;20(3):289-309 11696864 - Inhal Toxicol. 2001 Oct;13(10):851-75 8571091 - Scand J Work Environ Health. 1995 Oct;21(5):353-61 11341546 - Ind Health. 2001 Apr;39(2):161-7 16209704 - Part Fibre Toxicol. 2005 Oct 06;2:8 839555 - J Natl Cancer Inst. 1977 Mar;58(3):587-603 2306689 - Cancer. 1990 Mar 15;65(6):1449-55 21539476 - Inhal Toxicol. 1995;7(4):425-67 8543383 - Int Arch Occup Environ Health. 1995;67(5):343-6 17980576 - Eur J Cancer. 2007 Dec;43(18):2722-8 16040559 - Inhal Toxicol. 2005 Sep;17(10):497-537 2272321 - Environ Health Perspect. 1990 Aug;88:261-8 18096653 - Occup Environ Med. 2008 Sep;65(9):613-9 12475867 - Chest. 2002 Dec;122(6):2224-9 17455866 - Tumori. 2007 Jan-Feb;93(1):19-22 12855491 - Ann Occup Hyg. 2003 Jul;47(5):413-26 20798015 - Occup Environ Med. 2011 Feb;68(2):89-95 11845101 - Rev Epidemiol Sante Publique. 2001 Dec;49(6):523-9 12065376 - Chest. 2002 Jun;121(6):2044-51 7757162 - Occup Environ Med. 1995 Feb;52(2):105-9 16837114 - Regul Toxicol Pharmacol. 2006 Oct;46(1):42-62 10366897 - Ann Occup Hyg. 1999 Apr;43(3):155-66 15668258 - Ann Occup Hyg. 2005 Jun;49(4):295-307 24766058 - Crit Rev Toxicol. 2014 May;44(5):436-49 6095718 - Ann Occup Hyg. 1984;28(3):333-9 24649303 - Mol Clin Oncol. 2014 Jan;2(1):26-30 23287997 - BMJ. 2013;346:e8376 11696863 - Inhal Toxicol. 2001 Oct;13(10):823-49 7882917 - Environ Health Perspect. 1994 Oct;102 Suppl 5:133-7 22126592 - Cancer Sci. 2012 Mar;103(3):483-90 9227715 - Thorax. 1997 Jun;52(6):507-12 23121302 - Inhal Toxicol. 2012 Nov;24(13):928-9 12094100 - Epidemiology. 2002 Jul;13(4):445-53 20388033 - Inhal Toxicol. 2010 May;22(6):500-21 10968563 - Int Arch Occup Environ Health. 2000 Jun;73 Suppl:S60-8 8275791 - Chest. 1994 Jan;105(1):8-9 6279138 - Br J Ind Med. 1982 Feb;39(1):45-53 20386624 - Indian J Occup Environ Med. 2009 Aug;13(2):80-3 9356279 - Regul Toxicol Pharmacol. 1997 Oct;26(2):156-71 17053017 - Occup Environ Med. 2007 Aug;64(8):502-8 10880135 - Inhal Toxicol. 2000 May;12(5):359-99 1572439 - Eur Respir J. 1992 Mar;5(3):281-5 3436395 - Exp Pathol. 1987;32(3):129-52 9801022 - Am J Epidemiol. 1998 Nov 1;148(9):910-9 1494965 - J Occup Med. 1992 Jul;34(7):718-21 10450772 - Scand J Work Environ Health. 1999 Jun;25(3):222-6 24083862 - Am J Respir Crit Care Med. 2013 Oct 1;188(7):873 18236228 - Inhal Toxicol. 2008 Jan;20(2):139-47 8275722 - Chest. 1994 Jan;105(1):144-50 3655947 - J Occup Med. 1987 Aug;29(8):641-4 8742311 - Fundam Appl Toxicol. 1996 Feb;29(2):155-67 17717621 - Scand J Work Environ Health. 2007 Aug;33(4):286-92 12929149 - Am J Ind Med. 2003 Sep;44(3):291-7 15645436 - Int J Cancer. 2005 May 20;115(1):142-7 19001953 - J Occup Environ Med. 2008 Nov;50(11):1273-81 16221782 - N Engl J Med. 2005 Oct 13;353(15):1591-603 1415285 - Am J Ind Med. 1992;22(2):185-92 16814911 - Regul Toxicol Pharmacol. 2006 Aug;45(3):252-64 23471464 - Am J Respir Crit Care Med. 2013 May 1;187(9):977-82 1890486 - J Occup Med. 1991 Jul;33(7):770-3 14248731 - N Engl J Med. 1965 Mar 18;272:560-5 4377876 - Environ Health Perspect. 1974 Dec;9:313-5 |
References_xml | – ident: CIT0052 doi: 10.1136/oem.58.12.800 – volume: 48 start-page: 818 year: 1991 ident: CIT0193 publication-title: Br J Ind Med – ident: CIT0034 doi: 10.5271/sjweh.427 – ident: CIT0042 doi: 10.1136/oem.52.2.105 – ident: CIT0128 doi: 10.1080/08958370050198511 – ident: CIT0156 doi: 10.1002/ajim.4700220205 – ident: CIT0181 doi: 10.1093/jnci/58.3.587 – ident: CIT0160 doi: 10.2307/3428305 – volume: 5 start-page: 205 year: 2013 ident: CIT0096 publication-title: J Thorac Dis – ident: CIT0153 doi: 10.1186/1743-8977-2-8 – ident: CIT0015 doi: 10.1080/10408440802273156 – ident: CIT0147 doi: 10.2307/3432074 – volume-title: Occupational asbestosis and related diseases. Medical/Scientific Update year: 1989 ident: CIT0152 – ident: CIT0087 doi: 10.1289/ehp.94102s5133 – ident: CIT0195 doi: 10.1136/thx.52.6.507 – ident: CIT0001 doi: 10.1164/ajrccm-conference.2011.183.1_MeetingAbstracts.A4812 – volume: 86 start-page: 33 year: 2014 ident: CIT0070 publication-title: A prospective study on Italian workers exposed to asbestos. Oncology – ident: CIT0131 doi: 10.1006/rtph.1997.1153 – ident: CIT0091 doi: 10.1093/occmed/kqg051 – ident: CIT0044 doi: 10.1053/sonc.2002.30227 – ident: CIT0118 doi: 10.1164/ajrccm.157.4.9707131 – ident: CIT0062 doi: 10.1136/bmj.e8376 – ident: CIT0133 doi: 10.3109/08958379509015210 – ident: CIT0126 doi: 10.3109/08958379509015209 – ident: CIT0008 doi: 10.1016/j.rmr.2011.04.008 – volume: 51 start-page: 1057 year: 2009 ident: CIT0115 publication-title: JOEM – ident: CIT0100 doi: 10.1136/thx.51.Suppl_2.S9 – ident: CIT0132 doi: 10.1006/rtph.2000.1409 – ident: CIT0134 doi: 10.3109/08958379409003042 – ident: CIT0129 doi: 10.1080/08958370701866040 – volume: 40 start-page: 145 year: 1983 ident: CIT0041 publication-title: Br J Ind Med – volume: 10 start-page: 555 year: 1986 ident: CIT0169 publication-title: Am J Ind Health – ident: CIT0023 – ident: CIT0037 doi: 10.1093/annhyg/26.5.569 – volume: 49 start-page: 523 year: 2001 ident: CIT0058 publication-title: Rev Epidemiol Sante Publ – ident: CIT0018 doi: 10.1016/j.yrtph.2006.04.008 – volume: 40 start-page: 106 year: 1979 ident: CIT0067 publication-title: Am Ind Hyg Assoc J – ident: CIT0068 doi: 10.1016/0013-9351(82)90137-2 – ident: CIT0080 doi: 10.1002/ajim.20844 – ident: CIT0012 doi: 10.1002/ajim.20316 – ident: CIT0137 doi: 10.1378/chest.122.6.2224 – volume: 16 start-page: 1270 year: 1999 ident: CIT0113 publication-title: Rev Mal Respir – ident: CIT0140 doi: 10.1006/rtph.2001.1474 – volume: 70 start-page: 43950 year: 2005 ident: CIT0069 publication-title: Asbestos Exposure Limit; Proposed Rule – ident: CIT0108 doi: 10.1080/08958370701821375 – ident: CIT0173 doi: 10.1093/toxsci/kfs171 – ident: CIT0107 doi: 10.1289/ehp.97105s51261 – volume-title: Presented at the USEPA 2001 Asbestos Health Effects Conference year: 2001 ident: CIT0088 – ident: CIT0166 doi: 10.1080/08958370490505016 – ident: CIT0179 doi: 10.1378/chest.105.1.8 – ident: CIT0011 doi: 10.1023/A:1008239116237 – ident: CIT0072 doi: 10.1111/j.1349-7006.2011.02165.x – ident: CIT0167 doi: 10.1016/S0940-2993(96)80084-4 – ident: CIT0144 doi: 10.1006/faat.1996.0017 – ident: CIT0060 doi: 10.1002/ajim.10263 – volume: 7 start-page: 718 year: 1992 ident: CIT0110 publication-title: J Occup Med – ident: CIT0175 doi: 10.1093/annhyg/27.2.157 – ident: CIT0109 doi: 10.1164/rccm.201210-1911OC – ident: CIT0114 doi: 10.1289/ehp.9088311 – volume: 47 start-page: 413 year: 2003 ident: CIT0104 publication-title: Ann Occup Hyg – ident: CIT0185 doi: 10.1136/oem.52.2.97 – ident: CIT0157 doi: 10.1097/JOM.0b013e3181b68cef – ident: CIT0117 doi: 10.1378/chest.121.6.2044 – ident: CIT0106 doi: 10.5271/sjweh.1957 – volume: 88 start-page: 261 year: 1990 ident: CIT0057 publication-title: Environ Health Perspect – ident: CIT0030 doi: 10.1177/030089160709300104 – volume: 12 start-page: 381 year: 1996 ident: CIT0064 publication-title: J Occup Health Safety Aust NZ – ident: CIT0081 – volume-title: Refractory ceramic fibres, evaluation of the carcinogenicity and genotoxicity year: 2011 ident: CIT0082 – ident: CIT0112 doi: 10.1093/oxfordjournals.aje.a009717 – ident: CIT0045 doi: 10.1136/oem.2006.027748 – ident: CIT0146 doi: 10.1016/j.ajpath.2011.02.040 – start-page: 290 volume-title: Saisine 2004/012 Rapport Final Relatif aux Fibres year: 2007 ident: CIT0003 – ident: CIT0035 doi: 10.1097/00001648-199705000-00006 – ident: CIT0178 doi: 10.1056/NEJM196503182721104 – volume-title: Fact sheet on pleural plaques year: 2004 ident: CIT0163 – ident: CIT0017 doi: 10.1080/10408440701524592 – volume: 24 start-page: 928 year: 2012 ident: CIT0189 publication-title: Are airborne refractory ceramic fibers similar to asbestos in their carcinogenicity? Inhal Toxicol – ident: CIT0136 doi: 10.1136/oem.2009.048033 – ident: CIT0159 doi: 10.5271/sjweh.49 – volume: 2 start-page: 1028 year: 1984 ident: CIT0036 publication-title: Proceedings of the 6th International Pneumonoconiosis Conference – volume-title: Recommendation from the Scientific Committee on Occupational Exposure Limits for Refractory Ceramic fibres year: 2011 ident: CIT0177 – volume-title: Draft Report on Carcinogens. Substance Profile for Glass Wool Fibers (Respirable) as a Class year: 2010 ident: CIT0150 – ident: CIT0010 doi: 10.1136/thorax.55.10.860 – volume-title: Review of the U.S. Navy's exposure standard for manufactured vitreous fibers, subcommittee on manufactured vitreous fibers, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council year: 2000 ident: CIT0149 – ident: CIT0065 doi: 10.1007/BF00381385 – ident: CIT0105 doi: 10.1097/00001648-200207000-00013 – ident: CIT0141 doi: 10.1006/rtph.2000.1443 – volume: 81 volume-title: Man-made vitreous fibres year: 2002 ident: CIT0098 – ident: CIT0092 doi: 10.3892/mco.2013.197 – ident: CIT0174 doi: 10.5271/sjweh.2244 – ident: CIT0127 doi: 10.1080/089583700196103 – ident: CIT0071 doi: 10.1038/bjc.2013.514 – volume-title: Refractory Ceramic Fibers Coalition (RCFC) year: 1993 ident: CIT0184 – ident: CIT0078 doi: 10.2486/indhealth.MS1147 – ident: CIT0097 – ident: CIT0085 doi: 10.1006/taap.1998.8472 – ident: CIT0089 doi: 10.1177/1420326X9700600206 – ident: CIT0016 doi: 10.1111/j.1539-6924.1995.tb00312.x – ident: CIT0061 doi: 10.1016/j.mrfmmm.2004.06.011 – ident: CIT0111 doi: 10.1097/01.jom.0000052968.43131.b5 – volume: 2 start-page: 303 volume-title: Biological effects of man-made mineral fibers year: 1984 ident: CIT0056 – ident: CIT0176 – ident: CIT0025 doi: 10.3109/08958379609052913 – ident: CIT0031 doi: 10.2486/indhealth.39.161 – volume: 17 start-page: 497 year: 2005 ident: CIT0095 publication-title: lnhal Toxicol – ident: CIT0162 doi: 10.1136/oem.2004.018531 – ident: CIT0142 doi: 10.1081/DCT-100100112 – ident: CIT0026 doi: 10.1080/089583799197203 – volume: 12 start-page: 18 year: 1986 ident: CIT0048 publication-title: Scand J Work Environ Health – volume: 20 start-page: S104 year: 1994 ident: CIT0063 publication-title: Reg Toxicol Pharm – ident: CIT0090 doi: 10.1378/chest.105.1.144 – ident: CIT0013 doi: 10.1136/oem.57.7.488 – ident: CIT0154 doi: 10.1007/PL00014628 – ident: CIT0155 doi: 10.5694/mja11.10125 – ident: CIT0094 doi: 10.5271/sjweh.1145 – volume-title: Asbestos, risks of environmental and occupational exposure year: 2010 ident: CIT0083 – ident: CIT0172 doi: 10.1097/00043764-199107000-00008 – ident: CIT0043 doi: 10.5094/APR.2012.020 – ident: CIT0050 doi: 10.1023/A:1008871718323 – ident: CIT0119 doi: 10.1164/ajrccm.154.5.8912756 – volume: 12 start-page: 297 year: 1996 ident: CIT0123 publication-title: J Occup Health Saf Aust NZ – ident: CIT0084 doi: 10.1165/rcmb.2009-0206TR – ident: CIT0170 doi: 10.1183/09031936.96.09061206 – volume-title: Asbestos toxicity physiologic effects year: 2000 ident: CIT0006 – ident: CIT0032 doi: 10.1186/1746-1596-5-81 – ident: CIT0122 doi: 10.1016/j.yrtph.2011.02.009 – ident: CIT0007 doi: 10.1016/j.rmr.2012.02.012 – ident: CIT0190 doi: 10.1006/rtph.2001.1513 – ident: CIT0076 doi: 10.1002/ajim.20394 – ident: CIT0033 doi: 10.3109/10408444.2014.899558 – ident: CIT0120 doi: 10.1016/j.ejca.2007.09.018 – volume: 49 start-page: 295 year: 2005 ident: CIT0040 publication-title: Ann Occup Hyg – ident: CIT0101 doi: 10.5271/sjweh.1938 – ident: CIT0102 doi: 10.1093/annhyg/mef034 – ident: CIT0138 doi: 10.1016/S0003-4878(99)00018-6 – ident: CIT0143 doi: 10.2486/indhealth.39.65 – ident: CIT0028 doi: 10.4103/0019-5278.55124 – ident: CIT0183 doi: 10.2486/indhealth.39.183 – ident: CIT0051 doi: 10.1016/0013-9351(76)90009-8 – start-page: 1352 volume-title: Textbook of pulmonary and critical care medicine year: 2011 ident: CIT0014 – ident: CIT0049 doi: 10.1080/15298669391354612 – ident: CIT0027 doi: 10.4103/0019-5278.111753 – ident: CIT0059 doi: 10.1183/09031936.95.08122149 – ident: CIT0158 doi: 10.1097/JOM.0b013e31818345bb – ident: CIT0047 doi: 10.1080/02786828608959100 – volume: 67 start-page: 415 year: 1986 ident: CIT0055 publication-title: Br J Exp Pathol – volume: 39 start-page: 45 year: 1982 ident: CIT0165 publication-title: Br J Ind Med – ident: CIT0086 doi: 10.1006/faat.1996.0031 – ident: CIT0145 doi: 10.5271/sjweh.2326 – ident: CIT0077 doi: 10.1016/S0003-4878(98)00026-X – ident: CIT0046 doi: 10.1016/j.rmed.2005.04.017 – ident: CIT0186 doi: 10.3109/08958370903521224 – ident: CIT0024 doi: 10.1093/annhyg/41.inhaled_particles_VIII.224 – ident: CIT0021 doi: 10.1080/089583701752378142 – ident: CIT0019 doi: 10.1080/08958370390248888 – ident: CIT0099 doi: 10.1007/BF00385650 – ident: CIT0125 doi: 10.3109/08958379509015208 – ident: CIT0005 – ident: CIT0022 – ident: CIT0139 doi: 10.1080/089583701316941294 – ident: CIT0182 doi: 10.1136/oem.2007.035584 – ident: CIT0038 doi: 10.1164/rccm.201304-0655LE – volume: 69 start-page: 717 year: 1988 ident: CIT0054 publication-title: Br J Exp Pathol – ident: CIT0164 doi: 10.1056/NEJMra050152 – ident: CIT0151 doi: 10.1007/s004200100240 – volume: 30 start-page: 69 volume-title: Biological effects of mineral fibers year: 1980 ident: CIT0074 – ident: CIT0130 doi: 10.1016/j.yrtph.2006.05.003 – volume: 29 start-page: 641 year: 1987 ident: CIT0079 publication-title: J Occup Med – ident: CIT0192 doi: 10.1136/oem.2003.010165 – ident: CIT0029 doi: 10.2486/indhealth.45.379 – ident: CIT0103 doi: 10.1002/1097-0142(19900315)65:6<1449::AID-CNCR2820650633>3.0.CO;2-0 – ident: CIT0004 – ident: CIT0009 doi: 10.1080/0002889758507347 – ident: CIT0121 doi: 10.1002/ijc.20820 – ident: CIT0161 doi: 10.1016/S0232-1513(87)80044-0 – volume: 40 start-page: 273 year: 1983 ident: CIT0093 publication-title: Br J Ind Med – ident: CIT0148 – volume-title: ACC Review: Asbestos-related disease year: 2004 ident: CIT0002 – ident: CIT0196 doi: 10.1080/104732299302189 – ident: CIT0116 doi: 10.1097/JOM.0b013e31825296fd – volume: 5 start-page: 281 year: 1992 ident: CIT0171 publication-title: Eur Respir J doi: 10.1183/09031936.93.05030281 – start-page: 253 volume-title: Toxic and carcinogenic effects of solid particles in the respiratory tract year: 1994 ident: CIT0191 – ident: CIT0135 doi: 10.1016/S0140-6736(79)92468-1 – volume-title: Description and characterization of the ceramic fibres industry of the European Union year: 1995 ident: CIT0066 – ident: CIT0187 doi: 10.1080/15428119591016494 – ident: CIT0075 doi: 10.1007/s00204-010-0580-2 – ident: CIT0188 doi: 10.3109/08958378.2012.683892 – ident: CIT0194 doi: 10.1016/S0140-6736(05)73126-3 – ident: CIT0020 doi: 10.1080/089583701752378133 – ident: CIT0124 doi: 10.1097/00043764-199007000-00009 – start-page: 315 volume-title: Part of the medical radiology, diagnostic imaging and radiation oncology series year: 2006 ident: CIT0073 – ident: CIT0180 doi: 10.1093/annhyg/31.4B.731 – ident: CIT0168 doi: 10.1093/annhyg/28.3.333 – reference: 18096653 - Occup Environ Med. 2008 Sep;65(9):613-9 – reference: 7239672 - IARC Sci Publ. 1980;(30):69-78 – reference: 21162719 - Diagn Pathol. 2010;5:81 – reference: 9115020 - Epidemiology. 1997 May;8(3):259-68 – reference: 17455866 - Tumori. 2007 Jan-Feb;93(1):19-22 – reference: 8742311 - Fundam Appl Toxicol. 1996 Feb;29(2):155-67 – reference: 18027165 - Crit Rev Toxicol. 2007;37(10):839-86 – reference: 23989951 - Br J Cancer. 2013 Oct 1;109(7):1965-73 – reference: 10880135 - Inhal Toxicol. 2000 May;12(5):359-99 – reference: 10366897 - Ann Occup Hyg. 1999 Apr;43(3):155-66 – reference: 8919265 - Exp Toxicol Pathol. 1996 Jan;48(1):3-12 – reference: 10590549 - Appl Occup Environ Hyg. 1999 Nov;14(11):759-67 – reference: 24083862 - Am J Respir Crit Care Med. 2013 Oct 1;188(7):873 – reference: 17634686 - Ind Health. 2007 Jun;45(3):379-87 – reference: 15090665 - Occup Environ Med. 2004 May;61(5):438-41 – reference: 3812494 - Am J Ind Med. 1986;10(5-6):555-62 – reference: 8912756 - Am J Respir Crit Care Med. 1996 Nov;154(5):1405-10 – reference: 12724555 - Occup Med (Lond). 2003 May;53(3):209-12 – reference: 12475867 - Chest. 2002 Dec;122(6):2224-9 – reference: 23121302 - Inhal Toxicol. 2012 Nov;24(13):928-9 – reference: 3026035 - Scand J Work Environ Health. 1986;12 Suppl 1:18-25 – reference: 91808 - Lancet. 1979 Nov 17;2(8151):1074 – reference: 8869346 - Thorax. 1996 Aug;51 Suppl 2:S9-15 – reference: 22584686 - Toxicol Sci. 2012 Aug;128(2):461-70 – reference: 10968563 - Int Arch Occup Environ Health. 2000 Jun;73 Suppl:S60-8 – reference: 20068227 - Am J Respir Cell Mol Biol. 2010 Feb;42(2):133-9 – reference: 23287997 - BMJ. 2013;346:e8376 – reference: 16837114 - Regul Toxicol Pharmacol. 2006 Oct;46(1):42-62 – reference: 17099906 - Am J Ind Med. 2006 Dec;49(12):1066-9 – reference: 15645436 - Int J Cancer. 2005 May 20;115(1):142-7 – reference: 21539475 - Inhal Toxicol. 1995;7(4):469-502 – reference: 21345360 - Regul Toxicol Pharmacol. 2011 Jun;60(1):84-92 – reference: 2167956 - J Occup Med. 1990 Jul;32(7):594-604 – reference: 6307339 - Br J Ind Med. 1983 Aug;40(3):273-9 – reference: 8543383 - Int Arch Occup Environ Health. 1995;67(5):343-6 – reference: 20388033 - Inhal Toxicol. 2010 May;22(6):500-21 – reference: 7757174 - Occup Environ Med. 1995 Feb;52(2):97-104 – reference: 16221782 - N Engl J Med. 2005 Oct 13;353(15):1591-603 – reference: 12929149 - Am J Ind Med. 2003 Sep;44(3):291-7 – reference: 2835925 - Ann Occup Hyg. 1987;31(4B):731-54 – reference: 24649303 - Mol Clin Oncol. 2014 Jan;2(1):26-30 – reference: 7724842 - Regul Toxicol Pharmacol. 1994 Dec;20(3 Pt 2):S104-12 – reference: 19730396 - J Occup Environ Med. 2009 Sep;51(9):1075-87 – reference: 8275791 - Chest. 1994 Jan;105(1):8-9 – reference: 21641383 - Am J Pathol. 2011 Jun;178(6):2587-600 – reference: 14648356 - Inhal Toxicol. 2003 Dec;15(14):1387-419 – reference: 22642290 - Inhal Toxicol. 2012 Jun;24(7):416-24 – reference: 16169910 - Occup Environ Med. 2005 Oct;62(10):665-9 – reference: 11563601 - Int Arch Occup Environ Health. 2001 Aug;74(6):383-95 – reference: 3393849 - Scand J Work Environ Health. 1988 Jun;14(3):145-52 – reference: 17053017 - Occup Environ Med. 2007 Aug;64(8):502-8 – reference: 15288528 - Mutat Res. 2004 Sep 3;553(1-2):5-9 – reference: 23471464 - Am J Respir Crit Care Med. 2013 May 1;187(9):977-82 – reference: 11706147 - Occup Environ Med. 2001 Dec;58(12):800-10 – reference: 19749604 - J Occup Environ Med. 2009 Oct;51(10):1177-84 – reference: 11836664 - Semin Oncol. 2002 Feb;29(1):2-17 – reference: 10854503 - Occup Environ Med. 2000 Jul;57(7):488-94 – reference: 11341546 - Ind Health. 2001 Apr;39(2):161-7 – reference: 19001953 - J Occup Environ Med. 2008 Nov;50(11):1273-81 – reference: 21539476 - Inhal Toxicol. 1995;7(4):425-67 – reference: 10992539 - Thorax. 2000 Oct;55(10):860-3 – reference: 11341560 - Ind Health. 2001 Apr;39(2):65-74 – reference: 11407937 - Regul Toxicol Pharmacol. 2001 Jun;33(3):350-5 – reference: 9707503 - Toxicol Appl Pharmacol. 1998 Aug;151(2):262-75 – reference: 16586409 - Am J Ind Med. 2006 Jun;49(6):460-7 – reference: 12065376 - Chest. 2002 Jun;121(6):2044-51 – reference: 6523093 - Scand J Work Environ Health. 1984 Oct;10(5):293-8 – reference: 495442 - Am Ind Hyg Assoc J. 1979 Feb;40(2):108-17 – reference: 23776320 - Indian J Occup Environ Med. 2012 Sep;16(3):119-23 – reference: 8571091 - Scand J Work Environ Health. 1995 Oct;21(5):353-61 – reference: 8666112 - Eur Respir J. 1995 Dec;8(12):2149-73 – reference: 16814911 - Regul Toxicol Pharmacol. 2006 Aug;45(3):252-64 – reference: 24766058 - Crit Rev Toxicol. 2014 May;44(5):436-49 – reference: 20957726 - Am J Ind Med. 2010 Nov;53(11):1070-80 – reference: 1108627 - Am Ind Hyg Assoc J. 1975 Nov;36(11):811-9 – reference: 10905265 - Lancet. 2000 May 13;355(9216):1723-4 – reference: 1772796 - Br J Ind Med. 1991 Dec;48(12):818-24 – reference: 7597255 - Risk Anal. 1995 Apr;15(2):181-95 – reference: 21742228 - Rev Mal Respir. 2011 Jun;28(6):e11-7 – reference: 11114786 - Inhal Toxicol. 2000 Dec;12(12):1141-72 – reference: 11570360 - Inhal Toxicol. 2001 Sep;13(9):755-72 – reference: 6299326 - Br J Ind Med. 1983 May;40(2):145-52 – reference: 10450772 - Scand J Work Environ Health. 1999 Jun;25(3):222-6 – reference: 12074022 - Ann Occup Hyg. 2002 Mar;46(2):135-42 – reference: 2839895 - Scand J Work Environ Health. 1988;14 Suppl 1:49-51 – reference: 20798015 - Occup Environ Med. 2011 Feb;68(2):89-95 – reference: 15941656 - Respir Med. 2006 Jan;100(1):75-82 – reference: 8275722 - Chest. 1994 Jan;105(1):144-50 – reference: 17980576 - Eur J Cancer. 2007 Dec;43(18):2722-8 – reference: 18300048 - Inhal Toxicol. 2008 Feb;20(3):289-309 – reference: 6095718 - Ann Occup Hyg. 1984;28(3):333-9 – reference: 12094100 - Epidemiology. 2002 Jul;13(4):445-53 – reference: 14248731 - N Engl J Med. 1965 Mar 18;272:560-5 – reference: 7757162 - Occup Environ Med. 1995 Feb;52(2):105-9 – reference: 2272328 - Environ Health Perspect. 1990 Aug;88:311-7 – reference: 20386624 - Indian J Occup Environ Med. 2009 Aug;13(2):80-3 – reference: 9801022 - Am J Epidemiol. 1998 Nov 1;148(9):910-9 – reference: 11341549 - Ind Health. 2001 Apr;39(2):183-5 – reference: 12708148 - J Occup Environ Med. 2003 Apr;45(4):440-50 – reference: 11029264 - Regul Toxicol Pharmacol. 2000 Aug;32(1):14-21 – reference: 11845101 - Rev Epidemiol Sante Publique. 2001 Dec;49(6):523-9 – reference: 11696864 - Inhal Toxicol. 2001 Oct;13(10):851-75 – reference: 8742325 - Fundam Appl Toxicol. 1996 Feb;29(2):269-79 – reference: 16209704 - Part Fibre Toxicol. 2005 Oct 06;2:8 – reference: 18686078 - Crit Rev Toxicol. 2008;38 Suppl 1:49-73 – reference: 3655947 - J Occup Med. 1987 Aug;29(8):641-4 – reference: 954709 - Environ Res. 1976 Aug;12(1):59-74 – reference: 21173534 - Ind Health. 2011;49(2):166-72 – reference: 9356279 - Regul Toxicol Pharmacol. 1997 Oct;26(2):156-71 – reference: 839555 - J Natl Cancer Inst. 1977 Mar;58(3):587-603 – reference: 4001900 - Scand J Work Environ Health. 1985 Apr;11(2):117-22 – reference: 4377876 - Environ Health Perspect. 1974 Dec;9:313-5 – reference: 9227715 - Thorax. 1997 Jun;52(6):507-12 – reference: 9794173 - Cancer Causes Control. 1998 Aug;9(4):411-6 – reference: 23825744 - J Thorac Dis. 2013 Jun;5(3):205-6 – reference: 24401539 - Oncology. 2014;86(1):33-43 – reference: 7117223 - Environ Res. 1982 Aug;28(2):386-98 – reference: 10711399 - Drug Chem Toxicol. 2000 Feb;23(1):223-42 – reference: 2848570 - Br J Exp Pathol. 1988 Oct;69(5):717-37 – reference: 1415285 - Am J Ind Med. 1992;22(2):185-92 – reference: 10897848 - Rev Mal Respir. 1999 Dec;16(6 Pt 2):1270-7 – reference: 11846639 - Regul Toxicol Pharmacol. 2002 Feb;35(1):95-104 – reference: 1572439 - Eur Respir J. 1992 Mar;5(3):281-5 – reference: 11350196 - Regul Toxicol Pharmacol. 2001 Apr;33(2):138-46 – reference: 2272321 - Environ Health Perspect. 1990 Aug;88:261-8 – reference: 18236228 - Inhal Toxicol. 2008 Jan;20(2):139-47 – reference: 11696863 - Inhal Toxicol. 2001 Oct;13(10):823-49 – reference: 23101644 - Rev Mal Respir. 2012 Oct;29(8):1035-46 – reference: 9553658 - Ann Oncol. 1998 Feb;9(2):139-49 – reference: 7882917 - Environ Health Perspect. 1994 Oct;102 Suppl 5:133-7 – reference: 3045007 - Int Arch Occup Environ Health. 1988;60(6):389-93 – reference: 21895596 - Med J Aust. 2011 Sep 5;195(5):271-4 – reference: 2872911 - Br J Exp Pathol. 1986 Jun;67(3):415-30 – reference: 12855491 - Ann Occup Hyg. 2003 Jul;47(5):413-26 – reference: 16040559 - Inhal Toxicol. 2005 Sep;17(10):497-537 – reference: 6295247 - Ann Occup Hyg. 1982;26(1-4):569-82 – reference: 22796921 - J Occup Environ Med. 2012 Jul;54(7):781-8 – reference: 10380162 - Inhal Toxicol. 1999 Feb;11(2):111-30 – reference: 15668258 - Ann Occup Hyg. 2005 Jun;49(4):295-307 – reference: 17717621 - Scand J Work Environ Health. 2007 Aug;33(4):286-92 – reference: 1494965 - J Occup Med. 1992 Jul;34(7):718-21 – reference: 9563743 - Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1226-33 – reference: 3436395 - Exp Pathol. 1987;32(3):129-52 – reference: 2306689 - Cancer. 1990 Mar 15;65(6):1449-55 – reference: 16036750 - Inhal Toxicol. 2004 Oct-Nov;16(11-12):801-7 – reference: 1890486 - J Occup Med. 1991 Jul;33(7):770-3 – reference: 9400735 - Environ Health Perspect. 1997 Sep;105 Suppl 5:1261-3 – reference: 8804939 - Eur Respir J. 1996 Jun;9(6):1206-10 – reference: 7882918 - Environ Health Perspect. 1994 Oct;102 Suppl 5:139-43 – reference: 6279138 - Br J Ind Med. 1982 Feb;39(1):45-53 – reference: 6614727 - Ann Occup Hyg. 1983;27(2):157-71 – reference: 22126592 - Cancer Sci. 2012 Mar;103(3):483-90 – reference: 20737138 - Arch Toxicol. 2011 Mar;85(3):185-92 |
SSID | ssj0006037 |
Score | 2.196499 |
SecondaryResourceType | review_article |
Snippet | Abstract
In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant... In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant... |
SourceID | pubmedcentral proquest pubmed crossref informaworld informahealthcare |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 789 |
SubjectTerms | Animals Biopersistence Carcinogens - toxicity Ceramics - toxicity epidemiology fiber dimensions Humans Inhalation Exposure - adverse effects Kaolin - toxicity Lung Neoplasms - chemically induced mesothelioma Mineral Fibers - toxicity pleural plaques Rats refractory ceramic fiber Review rock wool |
Title | Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers |
URI | https://www.tandfonline.com/doi/abs/10.3109/08958378.2014.953276 https://www.ncbi.nlm.nih.gov/pubmed/25264933 https://www.proquest.com/docview/1620023470 https://pubmed.ncbi.nlm.nih.gov/PMC4245174 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED629mUwStv9aNq1aDDKBtXqSJZt7a3tFsJgI4wWuodhZEmmhdYpdfqQ_753luMk3Y_CHo11tsx3sk7Sfd8BvCtKSXW5U47oJjwWJuU6sX1OLNBYSY8zCHGHv31Phmfx13N1vsDip7RKWkOXQSii-VfT4DZFU4GEdCwPo0wr0kGnxKz4o1b4quQprApyVvTo6Oew-xcnUVDNRAtOJoE899enLE1O66106UWXiPVAzvRPQenD3MqFyWqwDmttlMmOgltswBNfbcL-KMhUTw_Y6Zx1VR-wfTaaC1hPN-F52MtjgaL0An6N5ozMmo0rhh2_ber0TJnFB11j25IyT9j7HyeDD8xSfaJqjK55aTHI_8RsV-ywZrTxyxraV7CpX8LZ4MvpyZC3ZRm4xXBvwo0QzupSO-G0SLR2JDAjhOkrGxslIhPJzKVCItBFmijnrUZgsqw0fe91oeQrWKnGld8Chgvk2DhT6rLwceqdTvvWGWmM8MYrWfRAzvDIbatZTqUzrnJcuxCK-QzFnFDMA4o94J3VTdDseKR9-hvUeTuU60css0WHyCfNLksZSqKQ2b9M386cJ8cRTcc0pvLjO3xhQokzMk6jHrwOztR9hlAYwGopsctLbtY1ILXw5TvV5UWjGk5H3Lj83P7_Lu_AM7oKTMw3sDK5vfO7GJJNir1m1O3B6tHx5-PBPWOJLPI |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEA-tPrRQitpWr9U2gkgLRneTze7GN5EeV784ygntQwnZJItCu1fc8-H--85s9vY8-yH0eTNJlt8kmUlmfkPITlEKrMudMUA3ZQk3GVOpjRlmgSZSeDhBMHf4_CIdXCYnX-QsmrBuwyrRhy4DUUSzV-Pixsvog8bFjNRBlCuJROgYmZXsKwljpY_JsoSzF6s3RF8H3WacRoE2EyQYioTsub_2snA6rbTcpVddJNY9PtM_WaX3gyvvnFb9FfK8NTPpUdCLVfLIV2tkdxh4qqd7dDRPu6r36C4dzhmsp2vkWbjMoyFH6QX5NpynZNZ0XFGY-E1TqGdKLXT0A9qWGHpC338-7n-gFgsUVWPQzWsLVv4htV21w5rizS9t8r6CTP2SXPY_jo4HrK3LwCzYexNmOHdWlcpxp3iqlEOGGc5NLG1iJI9MJHKXcQFIF1kqnbeAS5znpYm9V4UUr8hSNa78BqHgISfGmVKVhU8y71QWW2eEMdwbL0XRI2KGh7YtaTnWzviuwXlBFPUMRY0o6oBij7BO6mcg7XigffYb1Lpdy_UDkvldhdCT5pqlDDVRUOxfotsz5dGwpPGdxlR-fAsDphg5I5Is6pH1oEzdb3AJFqwSAqa8oGZdA6QLX_xSXV81tOH4xg3-5-v_n_I78mQwOj_TZ58uTt-Qp_glpGVukqXJza3fAvtsUrxtVuAvQacu9A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rSxwxEA9WoRRKUfu6PiMUacHUvWSzu-m3oj1O28pRFOyHErJ5oNDuiXt-uP--M5u9vTv7EPy8mSTLTJKZZH6_IeRNGQTW5c4ZaDdjKTc5U5ntM0SBplJ4OEEQO_z1KBuepIen8nQBxY9plRhDh0gU0ezVuLgvXNhtIsxE7SaFksiDjolZ6XslYajsDlmTBRz1YNHJ92G3F2dJZM0ECYYiETz3z16WDqf1lrr0rEvEukZn-jen9Hpu5cJhNVgnD1ovk36MZrFBVny1SbZHkaZ6ukOP56ireodu09GcwHq6Se7HuzwaIUoPyY_RHJFZ03FFYeKXTZ2eKbXQ0S9oGzDzhL79tjd4Ry3WJ6rGYJrnFpz8D9R2xQ5rihe_tIF9RZn6ETkZfDreG7K2LAOz4O5NmOHcWRWU407xTCmHBDOcm760qZE8MYkoXM4FKLrMM-m8VbCLFEUwfe9VKcVjslqNK_-UUAiQU-NMUKH0ae6dyvvWGWEM98ZLUfaImOlD25azHEtn_NQQu6AW9UyLGrWooxZ7hHVSF5Gz44b2-R-q1u1Srm-QLBYNQk-aW5YQS6Kg2P9Et2bGo2FF4zONqfz4CgbMMHFGpHnSI0-iMXW_wSU4sEoImPKSmXUNkC18-Ut1ftawhuMTN4Sfz24_5dfk7mh_oL8cHH1-Tu7hhwjKfEFWJ5dX_iV4Z5PyVbMAfwNP4C4m |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Perspectives+on+refractory+ceramic+fiber+%28RCF%29+carcinogenicity%3A+comparisons+with+other+fibers&rft.jtitle=Inhalation+toxicology&rft.au=Greim%2C+Helmut&rft.au=Utell%2C+Mark+J.&rft.au=Maxim%2C+L.+Daniel&rft.au=Niebo%2C+Ron&rft.date=2014-11-01&rft.pub=Informa+Healthcare+USA%2C+Inc&rft.issn=0895-8378&rft.eissn=1091-7691&rft.volume=26&rft.issue=13&rft.spage=789&rft.epage=810&rft_id=info:doi/10.3109%2F08958378.2014.953276&rft.externalDocID=10_3109_08958378_2014_953276 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-8378&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-8378&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-8378&client=summon |